Merendree Pharma SRL
The score of Merendree Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2023 → 2026: Equity +4 % Total assets -13 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Merendree Pharma's annual accounts
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Net result | 60,077 € | ||||
| Equity | 264,470 € | ||||
| Cash | 197,692 € | ||||
| EBITDA | 135,896 € | ||||
| Total assets | 450,925 € |
Filed annual accounts
- Year ended 30 Jun 2026filed on 12 Oct 2026
- Year ended 30 Jun 2025filed on 09 Dec 2025
- Year ended 30 Jun 2024filed on 29 Dec 2024
- Year ended 30 Jun 2023filed on 27 Nov 2023
- Year ended 30 Jun 2022filed on 08 Dec 2022
Merendree Pharma's financial analysis
- Solvency58.7%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Merendree Pharma
Merendree Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0504.865.006
- VAT number
- BE0504865006
- Peppol
- Registered · 0208:0504865006 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 07 Feb 2013
- Registered office
- 9850 Deinze
- Latest accounts
- 2026 · filed on 12 Oct 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Merendree Pharma (SRL) has been based in Deinze since 2013, active in: retail sale of pharmaceutical products. For 2026, it reports a net profit of 60,077 € and equity of 264,470 €; its revenue is not published. Its solvency stands at 58.7%, above the median of its sector (44.2%).
Companies similar to Merendree Pharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Delvigne Doumont Retail sale of pharmaceutical products Genappe · balance sheet 451,687 €
- Aporots Retail sale of pharmaceutical products Tervuren · balance sheet 449,560 €
- Apoteek Croket Retail sale of pharmaceutical products Antwerp · balance sheet 448,816 €
- Apotheek Generaal Retail sale of pharmaceutical products Antwerp · balance sheet 453,148 €
- Ancienne Pharmacie Quittelier Retail sale of pharmaceutical products Ath · balance sheet 448,413 €
- Smalle - Gheleyns Retail sale of pharmaceutical products Bruges · balance sheet 446,568 €
- Harmonie Pharma Retail sale of pharmaceutical products Brussels · balance sheet 456,132 €
- Farma V.T.B. Retail sale of pharmaceutical products Oud-Turnhout · balance sheet 456,718 €
Frequently asked questions about Merendree Pharma
What is the revenue of Merendree Pharma?
Merendree Pharma files its accounts in a format where revenue is optional: it is not published for 2026.
What is the VAT number of Merendree Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0504865006 for Merendree Pharma, if the company is VAT-registered. Its company number (CBE) is 0504.865.006.
Where is the registered office of Merendree Pharma?
According to the CBE register, the registered office of Merendree Pharma is in 9850 Deinze.
What is the equity of Merendree Pharma?
At the close of the 2026 financial year, the equity of Merendree Pharma amounts to 264,470 €, a solvency of 58.7% of total assets.
Who manages Merendree Pharma?
The register lists 1 active mandates at Merendree Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Merendree Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →